Echo Street Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Echo Street Capital Management's BMY Position: Q2 2023 in Review
Echo Street Capital Management sold out of Bristol-Myers Squibb (BMY) in Q2 2023, closing a stake of 8,417 shares — an estimated $583K sold.
Echo Street Capital Management first reported a position in BMY in Q4 2020 and held it in 5 quarters. The position peaked at $1.31M in Q4 2022. 2,480 funds tracked by Wall St. Rank hold BMY as of Q2 2023.
- Echo Street Capital Management reported no remaining Bristol-Myers Squibb position as of Q2 2023 after selling out during the quarter.
- Echo Street Capital Management sold 8,417 Bristol-Myers Squibb shares in Q2 2023, an estimated $583K.
- Echo Street Capital Management first reported a position in Bristol-Myers Squibb in Q4 2020 and held it in 5 quarters.
- Echo Street Capital Management's Bristol-Myers Squibb position peaked at $1.31M in Q4 2022.
- 2,480 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2023.
Based on Echo Street Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.